These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34359797)

  • 1. Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients.
    Montalbán-Hernández K; Cantero-Cid R; Lozano-Rodríguez R; Pascual-Iglesias A; Avendaño-Ortiz J; Casalvilla-Dueñas JC; Bonel Pérez GC; Guevara J; Marcano C; Barragán C; Valentín J; Del Fresno C; Aguirre LA; López Collazo E
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer.
    Montalbán-Hernández K; Casalvilla-Dueñas JC; Cruz-Castellanos P; Gutierrez-Sainz L; Lozano-Rodríguez R; Avendaño-Ortiz J; Del Fresno C; de Castro-Carpeño J; López-Collazo E
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of SIGLEC5-induced impairment of CD8
    Lozano-Rodríguez R; Avendaño-Ortíz J; Montalbán-Hernández K; Ruiz-Rodríguez JC; Ferrer R; Martín-Quirós A; Maroun-Eid C; González-López JJ; Fàbrega A; Terrón-Arcos V; Gutiérrez-Fernández M; Alonso-López E; Cubillos-Zapata C; Fernández-Velasco M; Pérez de Diego R; Pelegrin P; García-Palenciano C; Cueto FJ; Del Fresno C; López-Collazo E
    EBioMedicine; 2023 Nov; 97():104841. PubMed ID: 37890368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Serum Caveolin-1 a Useful Biomarker for Progression in Patients with Colorectal Cancer?
    Erdemli HK; Kocabas R; Salis O; Sen F; Akyol S; Eskin F; Akyol O; Bedir A; Sahin AF
    Clin Lab; 2016; 62(3):401-8. PubMed ID: 27156330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
    Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
    J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
    Hao JP; Ma A
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System.
    Montalbán-Hernández K; Cantero-Cid R; Casalvilla-Dueñas JC; Avendaño-Ortiz J; Marín E; Lozano-Rodríguez R; Terrón-Arcos V; Vicario-Bravo M; Marcano C; Saavedra-Ambrosy J; Prado-Montero J; Valentín J; Pérez de Diego R; Córdoba L; Pulido E; Del Fresno C; Dueñas M; López-Collazo E
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
    Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
    Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
    Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
    Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    BMC Endocr Disord; 2020 Jul; 20(1):113. PubMed ID: 32709256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients.
    Xia Y; Wang D; Zhang N; Wang Z; Pang L
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28543924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
    Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
    Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.